FibroBiologics Quote - FBLG

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.47

Bid

2.35

Offer

2.66

Volume

120,050

2.25 Day's Range 2.64

1.0779 52 Week Range 55.00

Market Cap

86.843M

Previous Close

2.32

Open

2.33

Last Trade

2.62

Last Trade Time

Financial Volume

US$ 287,126

VWAP

2.3917

Average Volume (3m)

446,864

Shares Outstanding

35,159,125

Dividend Yield

PE Ratio

-4.80

Earnings Per Share (EPS)

-0.54

Revenue

Net Profit

-19.06M

FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to... FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.fibrobiologics.com

Headquarters

Wilmington, Delaware, USA

Founded

FibroBiologics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FBLG. The last closing price for FibroBiologics was US$2.32. Over the last year, FibroBiologics shares have traded in a share price range of US$ 1.0779 to US$ 55.00.

FibroBiologics currently has 35,159,125 shares in issue. The market capitalisation of FibroBiologics is US$81.57 million. FibroBiologics has a price to earnings ratio (PE ratio) of -4.80.

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

HOUSTON, Oct. 11, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the...

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

HOUSTON, Sept. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on...

Form 8-K - Current report

FibroBiologics Engages Southern Star Research as CRO in Australia

HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on...

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

HOUSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.25	-9.19117647059	2.72	3	2.3	112725	2.64156865	CS
4	-0.66	-21.0862619808	3.13	4.14	2.3	377161	3.09207248	CS
12	-2.54	-50.6986027944	5.01	5.54	1.0779	446864	3.0400302	CS
26	-9.03	-78.5217391304	11.5	13.59	1.0779	302765	4.54029217	CS
52	-27.53	-91.7666666667	30	55	1.0779	246610	5.50781801	CS
156	-27.53	-91.7666666667	30	55	1.0779	246610	5.50781801	CS
260	-27.53	-91.7666666667	30	55	1.0779	246610	5.50781801	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CAMPCAMP4 Therapeutics Corporation	10.75 (2,587.50%)	378.47k
TWGTop Wealth Group Holding Ltd	US$ 7.14 (233.64%)	149.99M
NIVFNewGenIvf Group Ltd	US$ 0.98 (63.42%)	57.16M
ATIFATIF Holdings Ltd	US$ 1.235 (58.33%)	3.85M
VERBVerb Technology Company Inc	US$ 7.91 (51.82%)	15.55M
BYUBAIYU Holdings Inc	US$ 0.299 (-35.28%)	10.99M
TURBTurbo Energy SA	US$ 2.1511 (-29.01%)	2.83M
SMSTDefiance Daily Target 1.5X Short MSTR ETF	US$ 7.898 (-23.62%)	984.8k
VEEAVeea Inc	US$ 3.27 (-23.24%)	279.91k
INHDInno Holdings Inc	US$ 3.74 (-22.41%)	243.8k
JTAIJet AI Inc	US$ 0.1009 (23.50%)	340.09M
CDTConduit Pharmaceuticals Inc	US$ 0.116 (13.28%)	270.97M
NVDANVIDIA Corporation	US$ 134.80 (-0.01%)	170.27M
LUXHLuxUrban Hotels Inc	US$ 0.0532 (5.35%)	165.94M
TWGTop Wealth Group Holding Ltd	US$ 7.14 (233.64%)	154.23M